BriaCell Therapeutics Corp (NASDAQ:BCTX) does about 2.87M shares in volume on a normal day but saw 2203535 shares change hands in the recent trading day. The company now has a market cap of 23.88M USD. Its current market price is $0.66, marking a decrease of -0.18% compared to the previous close of $0.66. The 52 week high reached by this stock is $5.97 whilst the lowest price level in 52 weeks is $0.46.
BriaCell Therapeutics Corp (BCTX) has a 20-day trading average at $0.8552 and the current price is -88.94% off the 52-week high compared with 42.21% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.8410 and its 200-day simple moving average is $1.3461. If we look at the stock’s price movements over the week, volatility stands at 21.21%, which decreases to 15.14% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 41.44 to suggest the stock is neutral.
The consensus objective for the share price is $15.00, suggesting that the stock has a potential upside of 95.6% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on February 14, 2022 when H.C. Wainwright initiated the stock to “Buy” and issued a price target of $25.
The current price level is -22.82%, -21.51%, and -50.97% away from its SMA20, SMA50, and SMA200 respectively, with the BCTX price moving above the 50-day SMA on current market day. BriaCell Therapeutics Corp (BCTX) stock is down -31.05% over the week and 9.93% over the past month. Its price is -88.72% year-to-date and -83.87% over the past year.
To reach the target analysts have set, the stock logically needs to grow 95.6 percent from here.
The company has a return on equity of -202.12%. The beta has a value of 1.49.
